Merck & Co Inc (MRK)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$99.75
Buy
$100.30
$1.29 (+1.30%)
Prices updated at 13 Dec 2025, 00:56 EST
| Prices minimum 15 mins delay
Prices in USD
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 60,115m | 64,168m | |
| 43,989m | 48,975m | |
| 2,954m | 20,221m | |
| 4.91 | 31.51 | |
| 365m | 17,117m | |
| 6,907m | 25,706m | |
| Sales, General and administrative | 10,504m | 10,816m |
| Interest expenses | 1,146m | 1,271m |
| Provision for income taxes | 1,512m | 2,803m |
| Operating expenses | 41,035m | 28,754m |
| Income before taxes | 1,889m | 19,936m |
| Net income available to common shareholders | 365m | 17,117m |
| 0.14 | 6.76 | |
| Net interest income | -781m | -856m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 0.14 | 6.74 |
| Free cash flow per share | 5.1661 | 5.8368 |
| Book value/share | 16.2922 | 17.6062 |
| Debt equity ratio | 0.896277 | 0.744111 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 32,168m | 38,782m |
| Current liabilities | 25,694m | 28,420m |
| Total capital | 71,264m | 80,775m |
| Total debt | 35,055m | 37,111m |
| Total equity | 37,581m | 46,313m |
| Total non current liabilities | - | - |
| Loans | 33,683m | 34,462m |
| Total assets | 106,675m | 117,106m |
| Total liabilities | - | - |
| Cash and cash equivalents | 6,841m | 13,242m |
| Common stock | 2,532m | 2,528m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 12,773m | 6,909m |
| Cash dividends paid | -7,445m | -7,840m |
| 9,143m | 18,096m | |
| Investments (gains) losses | -14,083m | -7,734m |
| 6,909m | 13,318m | |
| Net income | - | - |
| 13,006m | 21,468m | |
| -3,863m | -3,372m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.